View in Browser

[link removed]

JOIN THE CONVERSATION

 

BREAST CANCER RESEARCH NEWS: WHAT YOU NEED TO KNOW
October 2020

 

[link removed]

Textured Implants May Be Linked to Breast Cancer Recurrence
A South Korean study of 650 women found that those who had textured
implants for reconstruction after breast cancer surgery had a small but
statistically significant increase in the risk of the breast cancer
coming back.

READ

 

[link removed]

Verzenio for Early-Stage Breast Cancer and Risk Reduction
Adding Verzenio to hormonal therapy after surgery to remove early-stage
hormone-receptor-positive, HER2-negative breast cancer with a high risk
of recurrence lowers that recurrence risk by about 25%, according to
early results from the monarchE study.
Read

 

[link removed]

Trodelvy Improves Outcomes for Previously Treated Metastatic
Triple-Negative Breast Cancer
Compared to chemotherapy, the immune targeted therapy Trodelvy offered
better progression-free survival and better overall survival for people
with metastatic triple-negative breast cancer that had been previously
treated with chemotherapy, according to the phase III ASCENT trial.
Read

 

[link removed]

Research Spotlight: ESMO 2020 Virtual Congress
Get a breakdown of the biggest headlines from the European Society for
Medical Oncology annual meeting. Our podcast episode explains the
SOLAR-1 trial that looked at specific PIK3CA-mutated breast cancers,
studies to treat early-stage hormone-receptor-positive HER2-negative
breast cancer, and more.
Listen

 

[link removed]

How Chemotherapy Choice Could Affect the Use of Tecentriq for Breast
Cancer
A study showed that combining Tecentriq and Abraxane improved overall
survival compared to Abraxane alone for people diagnosed with metastatic
PD-L1-positive triple-negative breast cancer, while another trial found
that combining Tecentriq with Taxol was no better than Taxol alone in
treating the same cancer type.
Listen

 

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

You subscribed to received updates. If you no longer wish to be
notified, unsubscribe here .

Breastcancer.org, 120 East Lancaster Ave, Suite 201, Ardmore, PA 19003, United States
Breastcancer.org is a nonprofit 501(c)(3) organization.